Background. The leaves of Hagenia abyssinica have been used in the management of diabetes mellitus in Ethiopian folk medicine. Thus, this study is aimed at investigating the in vitro alpha-amylase and alpha-glucosidase inhibitory and antioxidant activities of the crude extract and solvent fractions of H. abyssinica leaves. Methods. The in vitro alpha-amylase and alpha-glucosidase inhibitory and antioxidant activities of the plant extract were assessed using 3,5-dinitrosalicylic acid (DNSA), p-nitro-phenyl-a-D glucopyranoside (p-NPG), and 1,1-diphenyl-2-picrylhydrazyl (DPPH) assays, respectively. Each value of percent inhibition of alpha-amylase, alpha-glucosidase, and DPPH scavenging effect was presented as means +/- SEM (n=3). Results. The alpha-amylase inhibitory activity of the crude extract and solvent fractions was found to be concentration-dependent. The strongest activity was exhibited by the crude extract at the highest concentration with a percentage inhibition of 74.52% (IC50, 14.52 mu g/ml) followed by water fraction 68.24% (IC50, 16.31 mu g/ml), ethyl acetate fraction 61.57% (IC50, 18.73 mu g/ml), and chloroform fraction 56.87% (IC50, 21.57 mu g/ml) of H. abyssinica leaves. In the alpha-glucosidase inhibition assay, the maximum activity was exhibited by the aqueous fraction 62.54% (IC50, 11.67 mu g/ml) followed by ethyl acetate fraction 54.97% (IC50, 15.89 mu g/ml), crude extract 46.79% (IC50, >16.5 mu g/ml), and chloroform fraction 36.44% (IC50, >16.5 mu g/ml). In the antioxidant assay, the crude extract exhibited the highest antioxidant activity 86.36% (IC50, 10.25 mu g/ml) followed by water fraction 78.59% (IC50, 13.86 mu g/ml), ethyl acetate fraction 71.58% (IC50, 16.34 mu g/ml), and chloroform fraction 63.65% (IC50, 18.83 mu g/ml). Conclusion. This study has revealed that H. abyssinica leaves possess noticeable in vitro alpha-amylase and alpha-glucosidase inhibitory and antioxidant activities.